Viromed Medical founder plans further share placements to fund working capital, may cut stake to 25.1%

• Viromed plans additional placements of shares owned by founder Uwe Perbandt and his family to support operating funding.
• Sale proceeds are to be lent to the company to strengthen working capital.
• The Perbandt family has already provided EUR 1.7 million this year for working capital, studies, and regulatory approvals.
• For potential co-financing of a planned acquisition of relyon plasma, the family may sell more shares, cutting its stake to 25.1%.
• Placements are planned mainly with strategic investors, with a smaller portion sold in an orderly manner in the market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.